EVENT RESOURCES
- Wednesday, September 4, 2024
- Thursday, September 5, 2024
- Friday, September 6, 2024
- Saturday, September 7, 2024
| Name | Time | Virtual Session Link |
|---|---|---|
| Session I: Acute Lymphoblastic Leukemia | 9:00 AM - 11:36 AM | Go To Session |
| Plenary Session I | 12:56 PM - 1:16 PM | Go To Session |
| Session II: Myelodysplastic Syndromes | 1:16 PM - 2:56 PM | Go To Session |
| Session III: Acute Myeloid Leukemia | 3:26 PM - 6:00 PM | Go To Session |
| Name | Time | Virtual Session Link |
|---|---|---|
| Session IV: Chronic Myeloid Leukemia | 8:00 AM - 9:40 AM | Go To Session |
| Session V: MyeloproliferatIVe Neoplasms | 10:10 AM - 11:50 AM | Go To Session |
| Plenary Session II | 1:20 PM - 1:40 PM | Go To Session |
| Session VI: Multiple Myeloma | 1:40 PM - 3:56 PM | Go To Session |
| Session VII: Chronic Lymphocytic Leukemia | 4:26 PM - 6:24 PM | Go To Session |
| Name | Time | Virtual Session Link |
|---|---|---|
| Session VIII: T-Cell Lymphoma | 8:00 AM - 9:40 AM | Go To Session |
| Session IX: Indolent B-Cell Lymphoma | 10:10 AM - 11:42 AM | Go To Session |
| Plenary Session III | 1:07 PM - 1:27 PM | Go To Session |
| Session X: Aggressive B-Cell Lymphoma | 1:27 PM - 3:35 PM | Go To Session |
| Session XI: Mantle Cell Lymphoma | 4:05 PM - 5:17 PM | Go To Session |
| Session XII: Hodgkin Lymphoma | 5:17 PM - 5:53 PM | Go To Session |
| Name | Time | Virtual Session Link |
|---|---|---|
| Session XIII: Cellular therapy | 8:00 AM - 9:01 AM | Go To Session |
| Session XIV: Next Questions | 9:36 AM - 11:56 PM | Go To Session |
Time Zone: (UTC-05:00) Central Time (US & Canada) [Change Time Zone]
Time Zone: (UTC-05:00) Central Time (US & Canada) [Change Time Zone]
Dr. Bijal D. Shah MD, MS
H. Lee Moffitt Cancer Center
Senior Member, Clinical Research Medical Director for Hematologic Malignancies
H. Lee Moffitt Cancer Center
Senior Member, Clinical Research Medical Director for Hematologic Malignancies
Dr. Marion Subklewe MD
Ludwig-Maximilians-University of Munich
Professor and Consultant in Hematology/Oncology
Ludwig-Maximilians-University of Munich
Professor and Consultant in Hematology/Oncology
Dr. Eunice Sue Wang MD
Roswell Park Cancer Center
Director Chief, Leukemia Services and Professor of Oncology
Roswell Park Cancer Center
Director Chief, Leukemia Services and Professor of Oncology
Dr. Thomas Chatzikonstantinou MD
Centre for Research and Technology Hellas
Clinical Researcher and Supervisor of real-world studies at CERTH
Centre for Research and Technology Hellas
Clinical Researcher and Supervisor of real-world studies at CERTH
Dr. Suzanne Lentzsch MD, PhD
Columbia University
Professor of Medicine, Director of Multiple Myeloma and Amyloidosis Service
Columbia University
Professor of Medicine, Director of Multiple Myeloma and Amyloidosis Service
Dr. Ajay K Nooka MD, MPH, FACP
Emory University, Winship Cancer Institute
Professor and Director of the Department of Hematology/Medical Oncology, Associate Director of Clinical Research
Emory University, Winship Cancer Institute
Professor and Director of the Department of Hematology/Medical Oncology, Associate Director of Clinical Research
Dr. Noopur Raje MD
Massachusetts General Hospital
Professor of Medicine, Harvard Medical School, Director, Center for Multiple Myeloma
Massachusetts General Hospital
Professor of Medicine, Harvard Medical School, Director, Center for Multiple Myeloma
Dr. Saad Z. Usmani MD, MBA, FACP
Memorial Sloan Kettering Cancer Center
Chief of Myeloma Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
Chief of Myeloma Service, Department of Medicine
Dr. Charles Craddock CBE, FRCP (UK), FRCPath, DPhil, FMedSci
University of Birmingham
Professor of Haemato-oncology
University of Birmingham
Professor of Haemato-oncology
